What is the main business of Fortis Labs?

The main business activity of Fortis Labs focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 11, 2012.

Where is the headquarters located?

The headquarters is located at: ul. Adama Mickiewicza 29, 40-085 Katowice.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $0, representing an increase of 0.0% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $2,149. For comparison, in 2023 the loss was $1,335, meaning the company increased its loss by 53.0%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $2,149 in 2024, representing 100% of all operating expenses.

Fortis Labssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2012-07-11

Share capital

5,000.00 PLN

Registered address

ul. Adama Mickiewicza 29, 40-085 Katowice, Poland

Financials

Revenue history

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 261 days for 2023).

202514/07/2026
202410/07/2025
202302/04/2025
202230/06/2023
202103/10/2022
202014/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Authorized Representatives

Szymon Dawid Kamińskiage 46 – President

Dominik Marcin Kołodziejage 45 – Vice President

Manner of representation

In the case of a one-person management board, the President of the Management Board is authorized to make declarations on behalf of the company independently. In the case of a multi-member management board, the following are authorized jointly to make declarations on behalf of the company: two members of the management board, or a member of the management board jointly with a commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Szymon Dawid Kamińskiage 46	50	$675.31	50%
Dominik Marcin Kołodziejage 45	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2012-07-18 to 2025-07-07.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jun 3, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$1,282$1,282	Prezydent Miasta Katowice

Competitors

Name	Revenue	Website
NovoS.A.	$209,522,261.96	novo-sa.pl
AHP Logistykasp. z o.o.	$44,347,030.82	ahop.pl
Laerdal Medical Polandsp. z o.o.	$9,110,446.26	laerdal.com
Fortis Pharmaceuticalssp. z o.o.	$6,911,557.57	fortispharmaceuticals.pl
Steriwundsp. z o.o.	$2,832,891.51	steriwund.pl
Farmbudsp. z o.o.	$2,476,637.88	farmbud.eu
Medical Trade Polandsp. z o.o.	$2,257,474.02	meditradepol.com
Ortosilesiasp. z o.o. + limited partnership	$23,684.03	ortosilesia.pl
Biotangosp. z o.o.	–	biotango-med.com
MediwanaP.S.A.	–	mediwana.pl

Change history

Date	Event
2025-01-01	Business suspended
2021-08-06	Name change (Fortis Pharmaceuticals → Fortis Labs)
2015-12-08	Address change (Żniwna 28, 42-400, Zawiercie → Ul. Adama Mickiewicza 29, 40-085, Katowice)
2015-03-05	PKD change (Removed: 72 codes)
2012-07-11	Entered in the register

FAQ

Last updated: 2026-07-30